04-Nov-2026 19:55:20
AUROBINDO PHARMA Q2 FY27 ; NET PROFIT UP 33% AT ₹1,124 CR (YOY), UP 9% (QOQ)
REVENUE UP 24% AT ₹10,263 CR (YOY), UP 12% (QOQ) EBITDA UP 28% AT ₹2,156 CR (YOY), UP 15% (QOQ) MARGINS AT 21.0% VS 20.3% (YOY), 20.6% (QOQ)
Latest market headlines for AUROPHARMA on Terminal.
04-Nov-2026 19:55:20
REVENUE UP 24% AT ₹10,263 CR (YOY), UP 12% (QOQ) EBITDA UP 28% AT ₹2,156 CR (YOY), UP 15% (QOQ) MARGINS AT 21.0% VS 20.3% (YOY), 20.6% (QOQ)
03-Oct-2026 17:04:16
• The product will be manufactured at Unit-IV of APL Healthcare, a subsidiary of Aurobindo Pharma, and is slated for launch in Q3FY27. • The approved product t…
02-Oct-2026 18:08:25
• Apitoria Pharma Private Limited, a wholly owned subsidiary, is acquiring the Contract Research Services business of A1 Biochem Group. • A1 Biochem USA Inc.,…
01-Oct-2026 12:48:31
• Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma, acquired 100% stake in A1 Biochem Labs (India) Private Limited in July 2026.…
30-Sept-2026 21:25:35
AUROBINDO PHARMA : EXPANDS U.S. PRESENCE WITH ADQUEY™ LAUNCH FOR ATOPIC DERMATITIS
15-Sept-2026 18:13:35
• Apitoria Pharma Private Limited, a wholly owned subsidiary, was inspected by US FDA at its Unit-II API manufacturing facility. • The inspection took place fr…
15-Sept-2026 13:04:38
• Aurobindo Pharma received final USFDA approval for Beclomethasone Dipropionate HFA Inhalation Aerosol (40 mcg and 80 mcg). • This marks the company's first m…
12-Sept-2026 12:42:44
• A1 Biochem Labs (India) Private Limited, a step-down subsidiary of the Company, subscribed to 10,000 equity shares of USD 100 each of A1 Biochem USA Inc on S…
11-Sept-2026 17:32:40
• Apitoria Pharma Private Limited, a wholly owned subsidiary, underwent a US FDA inspection at its Unit-IV API manufacturing facility from September 07 to Sept…
01-Sept-2026 10:11:13
• Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma, has incorporated Avogent Lifesciences Private Limited in India. • Avogent Lif…
31-Aug-2026 10:09:53
• Lannett Company LLC, a wholly owned subsidiary of Aurobindo Pharma USA, Inc., has launched the generic equivalent of Advair Diskus® (fluticasone propionate a…
24-Aug-2026 09:02:42
• Lannett Company LLC, a wholly owned step-down subsidiary, underwent routine inspection by the US FDA from August 17-21, 2026. • The inspection concluded with…
21-Aug-2026 15:36:28
• AuroPeptides Ltd, a subsidiary, was inspected by the US FDA from August 17-21, 2026. • The inspection was routine and covered facility and equipment maintena…
10-Jul-2026 13:03:14
• PT Aurogen Pharma Indonesia, a wholly owned step-down subsidiary, incorporated PT Auro Pharm Indonesia in Indonesia. • PT Auro Pharm Indonesia is a new, whol…
02-Jul-2026 10:37:41
• Company's domestic branded generic pharmaceutical formulations products business has been transferred to Auropharm Limited, a wholly owned subsidiary. • The…
30-Jun-2026 09:54:59
• Aurobindo Pharma USA Inc., a subsidiary, has completed the acquisition of Lannett Company, Inc. • Lannett has become a wholly owned subsidiary of APUSA and w…
27-Jun-2026 10:39:32
• US FDA conducted an inspection at Auroactive Pharma Private Limited (a wholly owned subsidiary) • The inspection manufactured Active Pharmaceutical Ingredien…
25-Jun-2026 18:43:52
• Initial investment of ₹52 lakhs made, acquiring 26% equity share capital of Swarnaakshu Solar Power Private Limited. • Power purchase agreement entered for s…
22-Jun-2026 07:33:50
• Aurobindo Pharma USA, Inc., a subsidiary of Aurobindo Pharma Limited, received FTC approval for the acquisition of Lannett Company LLC. • The transaction is…
19-Jun-2026 21:11:10
• The United States Food and Drug Administration (US FDA) conducted a PAI at Eugia Steriles Private Limited, a 100% stepdown subsidiary of the Company. • The i…